Lifeward (LFWD) EPS (Basic) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 5.98% |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | -135.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135.96% |
| Dec 31, 2025 | -101.01% |
| Sep 30, 2025 | -30.50% |
| Jun 30, 2025 | -102.35% |
| Mar 31, 2025 | -87.31% |
| Dec 31, 2024 | -761.62% |
| Sep 30, 2024 | -80.01% |
| Jun 30, 2024 | -92.59% |
| Mar 31, 2024 | -108.97% |
| Dec 31, 2023 | -542.61% |
| Sep 30, 2023 | -69.72% |
| Jun 30, 2023 | -35.72% |
| Mar 31, 2023 | -11.29% |
| Dec 31, 2022 | -66.09% |
| Sep 30, 2022 | 41.95% |
| Jun 30, 2022 | 56.99% |
| Mar 31, 2022 | 61.74% |
| Dec 31, 2021 | 69.03% |
| Sep 30, 2021 | 73.41% |
| Jun 30, 2021 | 74.89% |
| Mar 31, 2021 | 75.22% |
| Dec 31, 2020 | 84.51% |
| Sep 30, 2020 | 12.64% |
| Jun 30, 2020 | 15.91% |
| Mar 31, 2020 | 1.74% |
| Dec 31, 2019 | 7.88% |
| Sep 30, 2019 | 9.47% |
| Jun 30, 2019 | -5.95% |
| Mar 31, 2019 | -30.69% |
| Dec 31, 2018 | -48.25% |
| Sep 30, 2018 | -81.90% |
| Jun 30, 2018 | -109.60% |
| Mar 31, 2018 | -122.12% |
| Dec 31, 2017 | -300.59% |
| Sep 30, 2017 | -27.98% |
| Jun 30, 2017 | -26.26% |
| Dec 31, 2016 | 70.89% |